Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
biopharma-reporter
2h
Alto Neuroscience’s depression drug trial fails at phase 2
The negative trial results have tanked the California-based biotech’s market value, with a 70% reduction in share price over ...
biopharma-reporter
6h
The FDA has approved Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59
The US pharma giant Pfizer recently announced that its respiratory syncytial virus (RSV) vaccine Abrysvo has received FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Settles civil lawsuit
Accused of plagiarism
Oldest person in US dies
Suffers 'debilitating' stroke
'Tarzan' star Ron Ely dies
Court orders new sentence
Courthouse attack charges
DOJ warns Musk's PAC?
Grizzly bear fatally struck
Joins Republican Party
Timberlake postpones shows
Seeks WI ballot exit
$3.9B storm relief proposal
Settles hazardous waste suit
Pneumococcal vax advice
911 calls from rally released
Existing home sales fall
Carbon removal firms report
New lead dust standards
Georgia repels cyberattack
Wins EU antitrust case
Unveils new AI rules
DNC office shootings arrest
Kentucky lawmaker dies
Israel strikes Lebanese city
FDA recalls antidepressant
Yelp disables reviews
Biden says lock up Trump
Feedback